https://feeds.newsfilecorp.com/company/5789 Latest news from Canntab Therapeutics Limited, as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Fri, 13 Mar 2026 03:25:22 -0400 https://www.newsfilecorp.com/images/newswire/customer-logos/5789.jpg https://feeds.newsfilecorp.com/company/5789 https://www.newsfilecorp.com/release/181020/Canntab-Therapeutics-Limited-Provides-Update-on-Application-for-Management-Cease-Trade-Order Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the "Corporation") announces that the Ontario Securities Commission (the "OSC") has rejected the Corporation's application for a management cease trade order (the "MCTO") dated September 14, 2023, as the Corporation is not viewed as having met all of the criteria for an MCTO.The Corporation filed the MCTO application with the OSC due to an anticipated delay in filing...<img src="https://api.newsfilecorp.com/newsinfo/181020/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Mon, 18 Sep 2023 13:40:00 -0400 en https://www.newsfilecorp.com/release/181020